Kuniharu Yamamoto

Tohoku Medical and Pharmaceutical University Hospital

Papers

Total Citations

H-Index

About

Kuniharu Yamamoto is a leading authority in hepatobiliary oncology, with a focused expertise in biliary tract cancer (BTC)—a rare and notoriously difficult-to-treat malignancy. His work critically addresses the stark disparities in tumor biology and surgical outcomes across BTC subtypes, particularly highlighting the elevated perioperative mortality associated with hilar cholangiocarcinoma and gallbladder cancer. Yamamoto’s major contribution lies in synthesizing current treatment paradigms while charting a forward-looking roadmap for therapeutic innovation. His most-cited paper, "Current insights and future perspectives of treatment strategies for biliary tract cancer," has already garnered 1 citation, signaling its immediate resonance within the surgical oncology community. By benchmarking clinical challenges and identifying gaps in existing management, Yamamoto provides a crucial framework for improving patient outcomes. His research serves as an essential resource for clinicians and researchers striving to reduce mortality and refine surgical strategies in this high-risk field.